This conference will draw attention to a novel approach in the management of lung disease, focusing on the physiopathology of “treatable traits”. The thinking behind this approach is to use strategic tools to explore the future of chronic lung disease management by looking ahead towards new perspectives, data and evidence from recent studies and real-life experiences.